Clinical trials
Phase 2 Cholangiocarcinoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basilea Pharmaceutica | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Fore Biotherapeutics | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
| Redx Pharma Ltd | 1 |
| UNICANCER | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 8 |
| Biliary Tract Neoplasms | 5 |
| Breast Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
| Bile Duct Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.